The global cancer cachexia market size is expected to reach USD 3.43 billion by 2032, according to a new study by Polaris Market Research. The report “Cancer Cachexia Market Share, Size, Trends, Industry Analysis Report, By Therapeutics (Progestogens, Corticosteroids, Combination Therapy, and Others); By Mechanism of Action; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The drastic increase in the prevalence of cancer, especially among the geriatric population, and growing awareness among healthcare professionals about the significance of cachexia contribute to the global market growth. With the increase in cancer patients, the risk of developing cancer cachexia among individuals also rises.
A growing number of government initiatives supporting cancer research and promoting the development of advanced therapies and drugs also propelled the market’s growth. There are key pharmaceutical companies involved in the development of new novel therapies that are specifically developed for addressing cancer cachexia.
Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/cancer-cachexia-market/request-for-sample
Cancer remains the leading cause of death for people between the ages of 40-79 years old, and 80% of cancer cases are associated with cachexia, and approx. 20% of patients die due to cancer cachexia; there is a significant need for further studies regarding its complex condition and the development of targeted therapies that are aimed at the specific molecular pathways associated with cachexia.
Cancer Cachexia Market Report Highlights
Polaris Market Research has segmented the cancer cachexia market report based on therapeutics, mechanism of action, distribution channel, and region:
Cancer Cachexia, Therapeutics Outlook (Revenue - USD Billion, 2024 - 2032)
Cancer Cachexia, Mechanism of Action Outlook (Revenue - USD Billion, 2024 - 2032)
Cancer Cachexia, Distribution Channel Outlook (Revenue - USD Billion, 2024 - 2032)
Cancer Cachexia, Regional Outlook (Revenue - USD Billion, 2024 - 2032)
Report Attributes |
Details |
Market size value in 2024 |
USD 2.48 billion |
Revenue forecast in 2032 |
USD 3.43 billion |
CAGR |
4.2% from 2024 – 2032 |
Base year |
2023 |
Historical data |
2019 – 2022 |
Forecast period |
2024 – 2032 |
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
Segments covered |
|
Regional scope |
|
Competitive Landscape |
|
Report Format |
|
Customization |
Report customization as per your requirements with respect to countries, region and segmentation. |
For Specific Research Requirements |